CTNM
Contineum Therapeutics
CTNM
CTNM
62 hedge funds and large institutions have $231M invested in Contineum Therapeutics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
11.26% more ownership
Funds ownership: 71.6% → 82.87% (+11%)
10% less capital invested
Capital invested by funds: $256M → $231M (-$25.1M)
Holders
62
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$7.26M | |
| 2 | +$5.09M | |
| 3 | +$3.89M | |
| 4 |
BlackRock
New York
|
+$2.91M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.85M |
Top Sellers
| 1 | -$2.53M | |
| 2 | -$1.94M | |
| 3 | -$1.28M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$1.1M |
| 5 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$744K |